﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>25</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2022</Year>
        <Month>03</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>All-Cause and Cause-Specific Mortality in Middle-Aged Individuals with Positive HBsAg: Findings from a Prospective Cohort Study</ArticleTitle>
    <FirstPage>139</FirstPage>
    <LastPage>147</LastPage>
    <ELocationID EIdType="doi">10.34172/aim.2022.24</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nazgol</FirstName>
        <LastName>Motamed-Gorji</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9426-5194</Identifier>
      </Author>
      <Author>
        <FirstName>Sareh</FirstName>
        <LastName>Eghtesad</LastName>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Sharafkhah</LastName>
      </Author>
      <Author>
        <FirstName>Sahar</FirstName>
        <LastName>Masoudi</LastName>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Darvishian</LastName>
      </Author>
      <Author>
        <FirstName>Layli</FirstName>
        <LastName>Eslami</LastName>
      </Author>
      <Author>
        <FirstName>Abdolsamad</FirstName>
        <LastName>Gharavi</LastName>
      </Author>
      <Author>
        <FirstName>Masoud</FirstName>
        <LastName>Khoshnia</LastName>
      </Author>
      <Author>
        <FirstName>Gholamreza</FirstName>
        <LastName>Roshandel</LastName>
      </Author>
      <Author>
        <FirstName>Amaneh</FirstName>
        <LastName>Shayanrad</LastName>
      </Author>
      <Author>
        <FirstName>Sanam</FirstName>
        <LastName>Hariri</LastName>
      </Author>
      <Author>
        <FirstName>Shahin</FirstName>
        <LastName>Merat</LastName>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Poustchi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4566-3628</Identifier>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Malekzadeh</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/aim.2022.24</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>10</Month>
        <Day>15</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>08</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <Abstract>Background: While hepatitis B virus (HBV) is the most prevalent cause of adult liver transplants in Iran, the mortality rates and leading causes of death in HBV patients are not well-understood. This study aimed to investigate all-cause and cause-specific mortality among HBsAg positive individuals in a large Iranian cohort. Methods: The Golestan Cohort Study includes 50045 individuals aged 40–75 residing in Iran’s Golestan province, enrolled during 2004–2008. HBsAg test was performed at baseline. For the present study, individuals with hepatitis C coinfection were excluded. All-cause mortality was considered as the primary outcome. The association between HBsAg and different mortality causes was evaluated using Cox proportional hazard models. P value&lt;0.05 was considered significant. Results: The current study included 49667 participants. After 11.33 (median) follow-up years, there were 7,686 total deaths, with 635 deaths in the HBsAg positive group. In the multivariate Cox proportional hazard model, HBsAg positive individuals had higher all-cause (adjusted hazard ratio [aHR]=1.15, 95% CI: 1.06–1.24) and liver-related mortality risk (aHR=7.13; 5.19–9.79). Mortality from colorectal and pancreatic cancers was higher among male HBsAg positive participants (aHRs=2.41 and 2.22, respectively). Nevertheless, cardiovascular diseases (CVDs) and extrahepatic malignancies were the leading causes of death among both HBsAg positive and negative individuals, and liver-related deaths contributed to an overall 10% of deaths in HBsAg positive patients. Conclusion: HBV is associated with significant mortality risk from different causes in Iranian adults. However, solely focusing on liver outcomes in Iranian HBV patients might result in overlooking non-liver events, especially CVD and extrahepatic cancers. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Cohort study</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hepatitis B virus</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Iran</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mortality</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>